SRJR Lifesciences LLP's Insider Trades & SAST Disclosures
SRJR Lifesciences LLP's most recent trade in Bafna Pharmaceuticals Ltd. was a Disposal of 2,830,766 Equity Shares done at an average price of Rs. 72 . Disclosure was reported to the exchange on March 31, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
SRJR Lifesciences LLP's has made SAST transactions in Bafna Pharmaceuticals Ltd. recently where a Disposal of 3,145,296 shares done . Disclosure was reported to the exchange on March 29, 2025.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bafna Pharma | SRJR Lifesciences LLP | Promoter | Disposal | 23 Apr 2025 | 3,145,296 | 17,640,016 (74.57%) | 13.30% | - | 27 Mar 2025 28 Mar 2025 |
SAST (29(2)) | - | Offer For Sale | |
| Bafna Pharma | SRJR LIFESCIENCES LLP | Promoter | Disposal | 31 Mar 2025 | 2,830,766 | 17,954,546 (75.90%) | 11.97% | 72 | 203,815,152 | 27 Mar 2025 27 Mar 2025 |
Insider Trading | Equity Shares | Others |
| Bafna Pharma | SRJR LIFESCIENCES LLP | Promoter | Disposal | 31 Mar 2025 | 314,530 | 17,640,016 (74.57%) | 1.33% | 72 | 22,646,160 | 28 Mar 2025 28 Mar 2025 |
Insider Trading | Equity Shares | Others |
| Bafna Pharma | SRJR LIFESCIENCES LLP | Promoter | Disposal | 30 Dec 2023 | 41,919 | 20,794,173 (87.90%) | 0.18% | 93.6 | 3,924,201 | 28 Dec 2023 29 Dec 2023 |
Insider Trading | Equity Shares | Market Sale |
| Bafna Pharma | SRJR LIFESCIENCES LLP | Promoter | Disposal | 28 Dec 2023 | 23,401 | 20,836,092 (88.08%) | 0.10% | 94.9 | 2,220,656 | 26 Dec 2023 27 Dec 2023 |
Insider Trading | Equity Shares | Market Sale |
| Bafna Pharma | SRJR LIFESCIENCES LLP (Revised) | Promoter | Disposal | 28 Dec 2023 | 30,000 | 20,859,493 (88.18%) | 0.13% | 98.8 | 2,963,351 | 22 Dec 2023 22 Dec 2023 |
Insider Trading | Equity Shares | Market Sale |
| Bafna Pharma | SRJR LIFESCIENCES LLP | Other | Disposal | 27 Dec 2023 | 30,000 | 20,859,493 (88.18%) | 0.13% | 98.8 | 2,963,351 | 22 Dec 2023 22 Dec 2023 |
Insider Trading | Equity Shares | Market Sale |
| Bafna Pharma | SRJR Lifesciences LLP | Promoter | Disposal | 13 Sep 2023 | 298,666 | 20,889,493 (88.30%) | 1.26% | - | 07 Sep 2023 08 Sep 2023 |
SAST (29(2)) | - | Offer For Sale | |
| Bafna Pharma | SRJR LIFESCIENCES LLP | Promoter | Disposal | 22 Sep 2022 | 8,897 | 21,188,159 (89.57%) | 0.04% | 103.0 | 916,568 | 14 Sep 2022 20 Sep 2022 |
Insider Trading | Equity Shares | Market Sale |
| Bafna Pharma | SRJR LIFESCIENCES LLP | Promoter | Disposal | 17 Sep 2022 | 9,883 | 21,197,056 (89.60%) | 0.04% | 109.7 | 1,083,892 | 07 Sep 2022 13 Sep 2022 |
Insider Trading | Equity Shares | Market Sale |
| Bafna Pharma | SRJR LIFESCIENCES LLP (Revised) | Promoter | Disposal | 03 Sep 2022 | 10,000 | 21,214,469 (89.68%) | 0.04% | 110.4 | 1,104,184 | 02 Sep 2022 02 Sep 2022 |
Insider Trading | Equity Shares | Market Sale |
| Bafna Pharma | SRJR LIFESCIENCES LLP | Promoter | Disposal | 03 Sep 2022 | 10,000 | 21,214,469 (89.68%) | 0.04% | 110.4 | 1,104,184 | 02 Sep 2022 02 Sep 2022 |
Insider Trading | Equity Shares | Market Sale |
| Bafna Pharma | SRJR LIFESCIENCES LLP | Promoter | Disposal | 17 Jun 2022 | 27,218 | 21,224,469 (89.72%) | 0.12% | 123.0 | 3,348,637 | 08 Jun 2022 15 Jun 2022 |
Insider Trading | Equity Shares | Market Sale |
| Bafna Pharma | SRJR LIFESCIENCES LLP | Promoter | Disposal | 09 Jun 2022 | 13,135 | 21,251,687 (89.84%) | 0.06% | 127 | 1,668,145 | 06 Jun 2022 06 Jun 2022 |
Insider Trading | Equity Shares | Market Sale |
| Bafna Pharma | SRJR LIFESCIENCES LLP | Promoter | Disposal | 06 Jun 2022 | 11,123 | 21,264,822 (89.89%) | 0.05% | 123 | 1,368,129 | 03 Jun 2022 03 Jun 2022 |
Insider Trading | Equity Shares | Market Sale |
| Bafna Pharma | SRJR LIFESCIENCES LLP | Promoter | Disposal | 06 Jun 2022 | 14,756 | 21,275,945 (89.93%) | 0.06% | 118.6 | 1,750,345 | 01 Jun 2022 02 Jun 2022 |
Insider Trading | Equity Shares | Market Sale |
| Bafna Pharma | SRJR LIFESCIENCES LLP | Promoter | Acquisition | 28 Dec 2020 | 21,290,701 | 21,290,701 (90%) | 90.00% | 26 | 553,558,226 | 10 Sep 2020 10 Sep 2020 |
Insider Trading | Equity Shares | Preferential Offer |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.